CMP---102.75 Shivalik Rasayan is one of India’s leading manufacturers of Organo-Phosphorous Insecticides. The company was established in 1981 in the Scenic Valley of Dehradun which is about 250 km from New Delhi with a mission to produce effective and environment friendly plant protection technical of International quality. Shivalik's manufacturing facilities are based in Dehradun on 21 acres of scenic land. The company uses the latest technology available in Agro Chemical along with the ultra modern techniques to control pollution for eco friendly environment. The Company has a professional board of Directors having 25 years of experience in running Agro Chemical Unit..... FINANCIALS: MARKET CAP (Rs Cr) 35.14 P/E 15.93 BOOK VALUE (Rs) 32.87 DIV (%) 0.00% Market Lot 1 INDUSTRY P/E 33.33 EPS (Mar 2015) 5.38 P/C 14.74 PRICE/BOOK 3.13 DIV YIELD.(%) -% FACE VALUE (Rs) 10.00 Sales have improved from 25cr to 41cr and NP from 0.61cr to 1.84cr during the last 5 years.For the first 6 months ended Sep 2015 during current fiscal , the company reported sales of 21.25cr and NP of 1.13cr.The ROCE is at an impressive 26% and D/E ratio at 0.04.The company is in the process of aquiring Medicamen Biotech ltd.The promoters are good management.Long term could yeild better returns.
Currently quoting at 15-16PE against industry average of 31 gives us an idea of the price movement.More so, keeping in view, the aquisition, which may add to the top and bottom line,the scrip could offer good appreciation in the medium to long term.Can be bought now and accumulated on the down side.
SRL today produces international quality Malathion Technical and Dimethoate Technical. The products of SRL are well established in Indian as well as foreign markets. For the last few years, it has been exporting 50 percent of its production to various countries around the world. The company has a long established reputation as a reliable and accepted supplier of quality products around the globe that endorses their commitment towards quality.
Shivalik Rasayan Ltd Share Holding Category No. of Shares Percentage Promoters 2,435,120 ---71.20 General Public 665,547--- 19.46 Other Companies 189,175 ---5.53 Financial Institutions 129,780 ----3.79 Others 328 ----0.01 Foreign - NRI 50 ----0.00 ------------------------------------------ Central Bank of India 112,570 3.29( out of 3.79%)
The Board of Directors of Shivalik Rasayan Ltd at its meeting held on September 16, 2015, has considered and approved the proposal to acquire substantial stake and control over M/s. Medicamen Biotech Limited, a company listed on BSE Limited, subject to the receipt of shareholders' approval in terms of Section 186 of the Companies Act, 2013 and such other laws as may be applicable. The Board considered and approved the draft Notice calling Extra-Ordinary General Meeting (EGM) for seeking shareholders' approval for the aforesaid transaction and accordingly, authorised Mr. Rahul Bishnoi and Mr. Ashwani Kumar Sharma (Directors), jointly and/or severally, to perform all such acts, deeds and things (including but not limited to appointment of Scrutinizer and signing the final copy of the Notice) to give effect to the above transaction.
Yes. Debt could go up.But the growth in revenues and bottom line should should be positive going forward.The stock should be loked upon for the medium/LONG term